Vito Quaranta

Q: What Schools Are Affiliated With Vito Quaranta

Vito Quaranta is affiliated with the following schools: University of California, Berkeley, Vanderbilt University, Johns Hopkins University, University of California, San Francisco

Vito Quaranta's AcademicInfluence.com Rankings

Vito Quaranta

Biology

#10142

World Rank

#13442

Historical Rank

Biochemistry

#1584

World Rank

#1715

Historical Rank

biology Degrees

Download Badge

Biology

Vito Quaranta's Degrees

PhD Biochemistry University of California, San Francisco
Bachelors Chemistry University of California, Berkeley

Why Is Vito Quaranta Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vito Quaranta's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. (1997) (1298)
A simplified laminin nomenclature. (2005) (849)
Integrin cytoplasmic domains mediate inside-out signal transduction (1994) (734)
Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment (2006) (707)
Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5 (2000) (668)
Intracellular transport of class II MHC molecules directed by invariant chain (1990) (551)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data (2019) (485)
Integrative mathematical oncology (2008) (409)
Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. (2001) (378)
Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts (2004) (344)
A novel vitronectin receptor integrin (α v β x ) is responsible for distinct adhesive properties of carcinoma cells (1989) (311)
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution (2003) (299)
Epithelial integrin alpha 6 beta 4: complete primary structure of alpha 6 and variant forms of beta 4 (1990) (285)
A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. (1989) (261)
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. (2021) (253)
Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules. (1991) (253)
EXPRESSION OF Ia‐LIKE ANTIGENS IN NORMAL HUMAN NONLYMPHOID TISSUES (1981) (232)
Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. (1991) (216)
Polarized integrin mediates human keratinocyte adhesion to basal lamina. (1990) (214)
Laminin-5 and hemidesmosomes: role of the alpha 3 chain subunit in hemidesmosome stability and assembly. (1996) (204)
Tales from the crypt[ic] sites of the extracellular matrix. (2003) (203)
Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis (2004) (193)
A function for the integrin alpha 6 beta 4 in the hemidesmosome. (1991) (185)
Complete amino acid sequence of a novel integrin beta subunit (beta 6) identified in epithelial cells using the polymerase chain reaction. (1990) (173)
Surface relocation of alpha 6 beta 4 integrins and assembly of hemidesmosomes in an in vitro model of wound healing (1991) (173)
Rapid Disruption of an Astrocyte Interaction With the Extracellular Matrix Mediated by Integrin α6β4 During Focal Cerebral Ischemia/Reperfusion (1997) (163)
The major laminin receptor of mouse embryonic stem cells is a novel isoform of the alpha 6 beta 1 integrin (1991) (161)
Laminin receptors in the retina: sequence analysis of the chick integrin alpha 6 subunit. Evidence for transcriptional and posttranslational regulation (1991) (158)
Beta 4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. (1994) (158)
A new isoform of the laminin receptor integrin alpha 7 beta 1 is developmentally regulated in skeletal muscle. (1993) (154)
Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens. (1981) (149)
Cadherin-Bound β-Catenin Feeds into the Wnt Pathway upon Adherens Junctions Dissociation: Evidence for an Intersection between β-Catenin Pools (2009) (140)
Clinically Relevant Modeling of Tumor Growth and Treatment Response (2013) (140)
Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. (2009) (132)
Human Hepatocellular Carcinoma (HCC) Cells Require Both α3β1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion (2001) (125)
Membrane-type Matrix Metalloproteinase-1 (MT1-MMP) Is a Processing Enzyme for Human Laminin γ2 Chain* (2005) (124)
Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells (2003) (119)
Inhibitory Role of α6β4-Associated Erbb-2 and Phosphoinositide 3-Kinase in Keratinocyte Haptotactic Migration Dependent on α3β1 Integrin (2001) (119)
Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent. (1980) (116)
Normalizing DNA microarray data. (2002) (115)
Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. (2000) (113)
Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. (2004) (109)
Mathematical modeling of cancer: the future of prognosis and treatment. (2005) (107)
Matrix metalloproteinases process the laminin-5 γ2-chain and regulate epithelial cell migration (2003) (104)
Quantifying Drug Combination Synergy along Potency and Efficacy Axes. (2019) (104)
Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells (1985) (102)
A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro (2008) (102)
The LG3 Module of Laminin-5 Harbors a Binding Site for Integrin α3β1 That Promotes Cell Adhesion, Spreading, and Migration* (2001) (101)
Microenvironment driven invasion: a multiscale multimodel investigation (2009) (98)
Fractional Proliferation: A method to deconvolve cell population dynamics from single-cell data (2012) (96)
Expression and Function of αvβ3 and αvβ5 Integrins in the Developing Pancreas (2000) (95)
A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). (1984) (94)
An off-lattice hybrid discrete-continuum model of tumor growth and invasion. (2010) (93)
Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression* (2008) (93)
Distribution of the alpha 1-alpha 6 integrin subunits in human developing and term placenta. (1991) (92)
Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development. (2001) (88)
An unbiased metric of antiproliferative drug effect in vitro (2016) (85)
A spatial model of tumor-host interaction: application of chemotherapy. (2008) (85)
Discrete Proteolysis of Focal Contact and Adherens Junction Components in Porphyromonas gingivalis-Infected Oral Keratinocytes: a Strategy for Cell Adhesion and Migration Disabling (2002) (81)
Proteolytic processing of laminin‐5 by MT1‐MMP in tissues and its effects on epithelial cell morphology (2004) (81)
Epithelial integrins. (1990) (80)
Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation (1987) (79)
Defining the role of laminin-332 in carcinoma. (2009) (78)
Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperfusion. (1997) (78)
Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. (2001) (78)
Invasion emerges from cancer cell adaptation to competitive microenvironments: quantitative predictions from multiscale mathematical models. (2008) (77)
A Monoclonal Antibody Inhibits Adhesion to Fibronectin and Vitronectin of a Colon Carcinoma Cell Line and Recognizes the Integrins αvβ3, αvβ5, and αvβ6 (1994) (77)
Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. (1999) (77)
The internal affairs of an integrin. (1991) (77)
αv Integrins mediate adhesion and migration of breast carcinoma cell lines (2004) (76)
Coating of titanium alloy with soluble laminin-5 promotes cell attachment and hemidesmosome assembly in gingival epithelial cells: potential application to dental implants. (1997) (76)
Rapid spreading and mature hemidesmosome formation in HaCaT keratinocytes induced by incubation with soluble laminin-5r. (1995) (76)
Morphogenetic effects of soluble laminin-5 on cultured epithelial cells and tissue explants. (1996) (76)
Network Analysis of the Focal Adhesion to Invadopodia Transition Identifies a PI3K-PKCα Invasive Signaling Axis (2012) (75)
Integrin distributions in renal cell carcinomas of various grades of malignancy. (1992) (74)
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer (2013) (73)
Monoclonal antibodies to HLA-A,B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells. (1980) (73)
Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts. (2002) (72)
Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types (1998) (72)
Activation of the Integrin Involves a Discrete Cation-binding Site That Regulates Conformation (*) (1996) (72)
Integrin α6Aβ1 Induces CD81-dependent Cell Motility without Engaging the Extracellular Matrix Migration Substrate (1997) (70)
Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin. (1998) (69)
Ia-like antigens on human T lymphocytes: relationship to other surface markers, role in mixed lymphocyte reactions, and structural profile. (1980) (69)
Establishment and Validation of Computational Model for MT1-MMP Dependent ECM Degradation and Intervention Strategies (2012) (68)
Toward a science of tumor forecasting for clinical oncology. (2015) (68)
Microenvironmental independence associated with tumor progression. (2009) (62)
Transgenic HLA-DRα faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to Eα in Eα 0 mutant mice (1989) (60)
New approaches to small cell lung cancer therapy : from the laboratory to the clinic. (2020) (60)
The contribution of age structure to cell population responses to targeted therapeutics. (2011) (58)
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers (2018) (58)
A mechanically coupled reaction–diffusion model that incorporates intra-tumoural heterogeneity to predict in vivo glioma growth (2017) (57)
Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity. (2017) (56)
Human Mammary Epithelial Cells Exhibit a Bimodal Correlated Random Walk Pattern (2010) (55)
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. (1989) (55)
The Activation State of the Integrin Affects Outside-in Signals Leading to Cell Spreading and Focal Adhesion Kinase Phosphorylation (*) (1995) (55)
Modelling of Cancer Growth, Evolution and Invasion: Bridging Scales and Models (2007) (54)
Defining signal thresholds in DNA microarrays: exemplary application for invasive cancer (2002) (54)
MHC class II molecules and immunoglobulins on peripheral blood lymphocytes of the bottlenosed dolphin, Tursiops truncatus. (1992) (53)
Tissue remodelling in liver diseases. (2003) (53)
Immunolocalization of Integrin α6β4 in Mouse Junctional Epithelium Suggests an Anchoring Function to both the Internal and the External Basal Lamina (1992) (52)
Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration. (2003) (52)
Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B. (1996) (51)
Changes in expression of monoclonal antibody epitopes on laminin-5r induced by cell contact. (1996) (51)
Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase (2012) (50)
DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway (2010) (49)
Cell Migration through Extracellular Matrix (2000) (48)
Linking Changes in Epithelial Morphogenesis to Cancer Mutations Using Computational Modeling (2010) (47)
Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. (1998) (47)
Laminin 5 in the Human Thymus: Control of T Cell Proliferation via α6β4 Integrins (1999) (44)
De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods. (2003) (44)
Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data (2015) (44)
Inhibitors (1991) (44)
Motility cues in the tumor microenvironment. (2002) (43)
Molecular cloning and characterization of CD4 in an aquatic mammal, the white whale Delphinapterus leucas (1999) (43)
Six monoclonal antibodies to human pancreatic cancer antigens. (1987) (42)
Charting the Fragmented Landscape of Drug Synergy. (2020) (42)
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition (2017) (40)
Immunoloealization of integrins in the normal and neoplastic colonic epithelium (1993) (40)
The human invariant chain is the core protein of the human class II- associated proteoglycan (1986) (39)
Ia-like antigens on freshly explanted human melanoma. (1981) (38)
Binding of monoclonal antibody (4F2) to its cell surface antigen on dispersed adenomatous parathyroid cells raises cytosolic calcium and inhibits parathyroid hormone secretion. (1987) (37)
Expression of Ia-like antigens on the vasculature of human kidney. (1981) (37)
A splice variant of alpha 6 integrin is associated with malignant conversion in mouse skin tumorigenesis. (1995) (36)
Integrin α6β4-erbB2 Complex Inhibits Haptotaxis by Up-regulating E-cadherin Cell-Cell Junctions in Keratinocytes* (2005) (36)
A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens. (1979) (35)
Quantitative measurement of alpha 6 beta 1 and alpha 6 beta 4 integrin internalization under cross-linking conditions: a possible role for alpha 6 cytoplasmic domains. (1994) (34)
A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6. (1994) (33)
Influence of cell cycle phase on apparent diffusion coefficient in synchronized cells detected using temporal diffusion spectroscopy (2011) (33)
A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer (2017) (32)
Gradient of Integrin α6A Distribution in the Myocardium During Early Heart Development (1995) (32)
Cancer Invasion: Watch Your Neighbourhood! (2003) (31)
Laminin‐332 cleavage by matriptase alters motility parameters of prostate cancer cells (2011) (31)
Evidence that laminin-5 is a component of the tooth surface internal basal lamina, supporting epithelial cell adhesion. (1999) (29)
Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization. (2008) (29)
Characterization of a Tight Molecular Complex between Integrin α6β4 and Laminin-5 Extracellular Matrix☆☆☆ (1998) (29)
MT1-MMP-mediated basement membrane remodeling modulates renal development. (2010) (29)
Laminin‐332–β1 integrin interactions negatively regulate invadopodia (2009) (28)
Ammonium chloride interferes with a distinct step in the biosynthesis and cell surface expression of human melanoma-type chondroitin sulfate proteoglycan. (1986) (28)
Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer1 (2018) (27)
Correction: Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity. (2017) (27)
New Approaches to SCLC Therapy: From the Laboratory to the Clinic (2020) (27)
A Nonquiescent "Idling" Population State in Drug-Treated, BRAF-Mutated Melanoma. (2018) (27)
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors (1994) (26)
Nest expansion assay: a cancer systems biology approach to in vitro invasion measurements (2009) (26)
Model-controlled hydrodynamic focusing to generate multiple overlapping gradients of surface-immobilized proteins in microfluidic devices. (2008) (26)
DNA microarrays: a novel approach to investigate genomics in trophoblast invasion--a review. (2000) (26)
Development of High-Throughput Quantitative Assays for Glucose Uptake in Cancer Cell Lines (2011) (25)
Structure of the human Ia-associated invariant (gamma)-chain gene: identification of 5' sequences shared with major histocompatibility complex class II genes. (1986) (25)
The invariant chain is a phosphorylated subunit of class II molecules. (1989) (25)
Trait variability of cancer cells quantified by high-content automated microscopy of single cells. (2009) (25)
Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. (2017) (25)
Dispersal of epithelial cancer cell colonies by lysophosphatidic acid (LPA) (2006) (24)
Activation of the integrin alpha v beta 3 involves a discrete cation-binding site that regulates conformation. (1996) (24)
An efficient and reliable method for cloning PCR-amplification products: a survey of point mutations in integrin cDNA. (1992) (23)
Ventricular-Subventricular Zone Contact by Glioblastoma is Not Associated with Molecular Signatures in Bulk Tumor Data (2019) (23)
The activation state of the integrin alpha IIb beta 3 affects outside-in signals leading to cell spreading and focal adhesion kinase phosphorylation. (1995) (23)
Integrin alpha6 maintains the structural integrity of the kidney collecting system. (2017) (22)
Tissue distribution of Ia-like antigens in different species: analysis with monoclonal antibodies. (1981) (22)
Integrin alpha 6A beta 1 induces CD81-dependent cell motility without engaging the extracellular matrix migration substrate. (1997) (21)
Quantifying heterogeneity and dynamics of clonal fitness in response to perturbation (2015) (21)
Human osteoclast-like cells selectively recognize laminin isoforms, an event that induces migration and activates Ca2+ mediated signals. (1996) (21)
Integrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes. (2005) (21)
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery (2021) (20)
Differential regulation of integrins and extracellular matrix binding in epidermal differentiation and squamous tumor progression. (1996) (19)
Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again! (2017) (19)
Integrin α3β1 regulates kidney collecting duct development via TRAF6-dependent K63-linked polyubiquitination of Akt (2015) (18)
Metabolic plasticity meets gene regulation (2019) (18)
A Decreased Ratio of Laminin-332 β3 to γ2 Subunit mRNA is Associated with Poor Prognosis in Colon Cancer (2009) (17)
ASCL1 represses a SOX9+ neural crest stem-like state in small cell lung cancer (2021) (17)
The Major Laminin Receptor of Mouse Embryonic Stem Cells Is a Novel Isoform of the a 6 ß 1 Integrin (2002) (16)
Antibody-induced activation of beta1 integrin receptors stimulates cAMP-dependent migration of breast cells on laminin-5. (2000) (16)
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data (2019) (16)
Isolation of Ia-like antigen-bearing cells from human peripheral lymphocytes through the use of a monoclonal antibody to framework determinants of Ia-like antigens. (1980) (15)
Serological, functional, and immunochemical characterization of a monoclonal antibody (MoAb Q2/70) to human Ia-like antigens. (1980) (15)
Natural cytotoxicity and antibody-dependent cellular cytotoxicity of human lymphocytes depleted of HLA-DR bearing cells with monoclonal HLA-DR antibodies. (1980) (15)
CellAnimation: an open source MATLAB framework for microscopy assays (2012) (15)
Quantitative measurement of α6β1 and α6β4 integrin internalization under cross-linking conditions: a possible role for α6 cytoplasmic domains (1994) (15)
Computational investigation of intrinsic and extrinsic mechanisms underlying the formation of carcinoma. (2012) (14)
Characterization of the specificity of DR monoclonal antibodies. (1979) (14)
The free and the β2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28 (2004) (14)
Integrins and laminins in tissue remodeling. (1997) (14)
Drug-Tolerant Idling Melanoma Cells Exhibit Theory-Predicted Metabolic Low-Low Phenotype (2019) (14)
Monoclonal antibody-mediated modulation of parathyroid hormone secretion by dispersed parathyroid cells. (1987) (13)
Automated Analysis of Cell-Matrix Adhesions in 2D and 3D Environments (2015) (13)
Immunolocalization of integrin alpha 6 beta 4 in mouse junctional epithelium suggests an anchoring function to both the internal and the external basal lamina. (1992) (13)
Characterization of Morphological and Cytoskeletal Changes in MCF10A Breast Epithelial Cells Plated on Laminin-5: Comparison with Breast Cancer Cell Line MCF7 (2001) (13)
Effect of Tunicamycin on the Assembly and Antigenicity of HLA Antigens: Analysis with Monoclonal Antibodies (1981) (13)
Serologically detectable human melanoma-associated antigens are not genetically linked to HLA-A and B antigens. (1979) (13)
Sulfated N-linked oligosaccharides in mammalian cells. III. Characterization of a pancreatic carcinoma cell surface glycoprotein with N- and O-sulfate esters on asparagine-linked glycans. (1988) (12)
Mode of adsorption and orientation of an extracellular matrix protein affect its cell-adhesion-promoting activity. (1998) (12)
What Lies Beneath: Looking Beyond Tumor Genetics Shows the Complexity of Signaling Networks Underlying Drug Sensitivity (2013) (12)
The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region (2004) (11)
An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability (2021) (11)
Bimodal analysis reveals a general scaling law governing nondirected and chemotactic cell motility. (2010) (11)
Not all noise is waste (2010) (11)
Characterization of a tight molecular complex between integrin alpha 6 beta 4 and laminin-5 extracellular matrix. (1998) (11)
Gradient of integrin alpha 6A distribution in the myocardium during early heart development. (1995) (11)
Changes in Ia-like antigen expression on malignant human cells (2005) (11)
Characterization of DR antigens on cultured melanoma cells by using monoclonal antibodies. (1980) (11)
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer. (2022) (10)
Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits (2005) (10)
The role of a recombinant fragment of laminin-332 in integrin alpha3beta1-dependent cell binding, spreading and migration. (2010) (10)
Cancer Hallmarks Define a Continuum of Plastic Cell States between Small Cell Lung Cancer Archetypes (2021) (10)
Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: Analysis of the role of Ia-like antigens with monoclonal antibodies (2005) (9)
Migration of isogenic cell lines quantified by dynamic multivariate analysis of single-cell motility (2008) (9)
Derivation and experimental comparison of cell-division probability densities. (2014) (9)
Rosetting of human T lymphocytes with goat red blood cells: effect of treatment with 2-aminoethylisothiouronium bromide (AET) and comparison with AET treated sheep red blood cells. (1979) (9)
Epitope mapping of function‐blocking monoclonal antibody CM6 suggests a “weak” integrin binding site on the laminin‐332 LG2 domain (2010) (8)
Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens. (1981) (8)
Leveraging Mathematical Modeling to Quantify Pharmacokinetic and Pharmacodynamic Pathways: Equivalent Dose Metric (2019) (8)
Modeling of Effects of Nutrient Gradients on Cell Proliferation in Microfluidic Bioreactor (2007) (8)
Lack of DR antigens on human B-lymphocyte-mouse fibroblast hybrids that express HLA-A,B antigens. (1979) (7)
A recurrent idiotype on monoclonal anti-human Ia antibodies (1982) (7)
Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal (2010) (7)
Receptor Association to the Cytoskeleton and Integrins by Activating Src-Focal Adhesion Kinase and Induces Clustering of HER 2 β Transforming Growth Factor (2009) (7)
An ELISA for detection of DNA-bound carcinogen using a monoclonal antibody to N-acetoxy-2-acetylaminofluorene-modified DNA. (1987) (7)
Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses. (2013) (7)
Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC (2021) (6)
Use of monoclonal antibodies to investigate immunologic cross-reactivity of histocompatibility antigens from various animal species. (1980) (6)
ACDC: Automated Cell Detection and Counting for Time-Lapse Fluorescence Microscopy (2020) (6)
Altered TGF‐α/β signaling drives cooperation between breast cancer cell populations (2016) (6)
Level of Ia-like antigens on human B and T lymphocytes. (1981) (5)
Beyond PD-L1: B7-H6 emerges as a potential immunotherapy target in small cell lung cancer. (2021) (5)
A Consensus Framework Unifies Multi-Drug Synergy Metrics (2019) (5)
The HLA-class II-associated chondroitin sulfate proteoglycan expressed by class II positive T and monocyte-like cell lines is larger than that expressed by EBV-transformed B-lymphoblastoid cell lines. (1987) (5)
An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells (2020) (4)
Abstract B27: Phenotypic plasticity and heterogeneity in small cell lung cancer (SCLC): Novel molecular subtypes and potential for targeted therapy. (2014) (4)
Laminins and Cancer Progression (2010) (4)
Thunor: visualization and analysis of high-throughput dose–response datasets (2019) (4)
Characterization of Human Null Cells Isolated from Peripheral Lymphocytes by a Simultaneous Double‐Rosetting Procedure (1981) (4)
Distinctive Functions of α6β4 and Other Integrins in Epithelial Cells (1994) (4)
A drift-diffusion checkpoint model predicts a highly variable and growth-factor-sensitive portion of the cell cycle G1 phase (2018) (3)
Structure of the human Ia-associated invariant ( y )-chain gene : Identification of 5 ' sequences shared with major histocompatibility complex class II genes ( genomic library / nucleotide sequence ) (3)
Integrin Expression and Epithelial Cell Differentiation (1993) (3)
Small Cell Lung Cancer subtypes identified by systems-level modeling of transcription factor networks (2018) (3)
Variable Cell Line Pharmacokinetics Contribute to Non-Linear Treatment Response in Heterogeneous Cell Populations (2018) (3)
Disruption of Redox Balance Enhances the Effects of BRAF-inhibition in Melanoma Cells (2019) (3)
HLA-DR antigens and mitogenic factors released by PWM-stimulated T lymphocytes share the framework determinant recognized by the monoclonal antibody Q5/13. (1981) (3)
Conditionally active STAT1 and its functional role in tumor progression and invasion (2006) (3)
Evidence for a K+ channel requirement in spreading of rat basophilic leukemia cells on fibronectin-coated surfaces. (1996) (3)
A transcription factor network model explains heterogeneity and reveals a novel hybrid phenotype in Small-Cell Lung Cancer . Authors / Affiliations (2016) (2)
Multi-Network Modeling of Cancer Cell States (2012) (2)
Visualization and analysis of high-throughput in vitro dose–response datasets with Thunor (2019) (2)
Monoclonal and polyclonal xenoantibodies to the HLA-A, B, C antigenic molecular complex do not affect the functional activity of C3 receptors. (1980) (2)
Dynamics of drug response informs rational combination regimens (2019) (2)
HLA Polyclonal and Monoclonal Xenoantibodies (1981) (2)
A unifying framework disentangles genetic, epigenetic, and stochastic sources of drug-response variability in an in vitro model of tumor heterogeneity (2020) (2)
T Cell Recognition of Major Histocompatibility Complex Antigens in HLA Class II Transgenic Mice (1990) (2)
ASCL1 represses a latent osteogenic program in small cell lung cancer in multiple cells of origin (2020) (1)
BIOCHEMICAL AND FUNCTIONAL PROFILES OF TWO UNIQUE MELANOMA ASSOCIATED ANTIGENS (1985) (1)
Cooperative RNA degradation stabilizes intermediate epithelial-mesenchymal states and supports a phenotypic continuum (2022) (1)
Cross-reactivity between human and murine lymphocyte antigens (1981) (1)
Identifying mechanisms driving the early response of triple negative breast cancer patients to neoadjuvant chemotherapy using a mechanistic model integrating in vitro and in vivo imaging data (2022) (1)
Effect of polyclonal and monoclonal HLA-DR xenoantibodies on xenogeneic mixed lymphocyte reactions (2005) (1)
Ventricular-Subventricular Zone Contact by Glioblastoma is Not Associated with Molecular Signatures in Bulk Tumor Data (2018) (1)
Abstract A09: Predicting response to whole brain radiotherapy in a murine model of glioma (2017) (1)
Measurements of Mean Nuclear and Cell Sizes Using Ultra-Short Diffusion Times (2009) (1)
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma (2022) (1)
Tumor cell (cid:1) 3 (cid:2) 1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis (2004) (1)
Evidence for Bigfoot? An Investigation of the Mill Creek 'Sasquatch Prints' (2019) (1)
Organoids as a Systems Platform for SCLC Brain Metastasis (2022) (1)
Immunodetection of integrins in the normal and neoplastic colon (1992) (1)
Vanderbilt PC9 cell line exposed to varying concentrations of erlotinib (2014) (0)
VP29.06: Cell‐free DNA screening for fetal aneuploidy by targeted method based on microarray quantitation as primary test in the average risk population: results from a single European laboratory (2020) (0)
Abstract 2894: Overcoming intrinsic resistance toBRAF-inhibitors by modulating redox balance inBRAF-mutated melanoma cells (2019) (0)
Laminin 5 in the Human Thymus: Control of T Cell Proliferation via (cid:97) 6 (cid:98) 4 Integrins (1999) (0)
Validating mathematical tumor invasion model simulations using xenograft mouse models of cancer invasion. (2007) (0)
Abstract 670: Molecular basis of the idling state uncovers vulnerabilities suitable to sequential targeting in melanoma (2019) (0)
Ralph A. Reisfeld, PhD: In Memoriam (1926–2020) (2021) (0)
Integrative mathematical modeling of cancer invasion. (2006) (0)
Abstract 3761: Distinct transcriptional programs drive phenotypic heterogeneity in small cell lung cancer (2015) (0)
Variation of ADC with Cell Cycle Phases : A Study Using Synchronized HL-60 Cells (2009) (0)
Abstract 3403: A stochastically arising subpopulation of B-RafV600E-expressing melanoma continues division in the presence of vemurafenib. (2013) (0)
Transduction of mutated or wild type beta-catenin in a naturally beta-catenin nullosomic tumor cell line leads to elevated S100A4/mts-1/metastasin expression (2004) (0)
Surface Relocation ofA1pha6Beta4 Integrins and Assembly ofHemidesmosomes in an In Vitro Model ofWound Healing (2002) (0)
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth (2023) (0)
The Integrin α 6β4 in Epithelial and Carcinoma Cells (2017) (0)
Abstract A14: Predicting the response of triple negative breast cancer to doxorubicin (2017) (0)
Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines (2022) (0)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data (2019) (0)
Tumor DNA Copy Number Alterations Reveal Activation Of The Focal Adhesion Pathway In Small Cell Lung Cancer (2010) (0)
Mathematical Oncology Microenvironmental Independence Associated with Tumor Progression (2009) (0)
Evaluation of immune checkpoints in small cell lung cancer: implications for immunotherapy (2020) (0)
Functional analysis and topography of integrins in human epithelial cells (1990) (0)
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses (2022) (0)
Abstract 5216: Gene co-expression network analysis of small cell lung cancer (SCLC) identifies new subclasses and novel therapeutic targets including Src family kinase Fyn and Spleen Tyrosine Kinase Syk. (2013) (0)
Adaptation-driven Models of Cancer Invasion: Experimental Parameterization and Validation (2008) (0)
Abstract 2018: Systems biology modeling of cellular radiosensitivity: A heterogeneity signature in the clonogenic assay (2010) (0)
Functional Analysis of Alpha-6 Integrin Cytoplasinic Domains. (1997) (0)
DAMD 1794-J-4155 TITLE : Functional Analysis of Alpha-6 Integrin Cytoplasmic Domains (0)
A heterogeneous drug tolerant persister state in BRAF-mutant melanoma is characterized by ion channel dysregulation and susceptibility to ferroptosis (2022) (0)
Abstract 4626: Quantifying erlotinib response variability in EGFR-addicted cells. (2013) (0)
Quantitative Approaches to Heterogeneity and Growth Variability in Cell Populations (2014) (0)
Binding of Integrins to Laminins (2007) (0)
Abstract 1845: Sensitivity of PC9 cells to erlotinib is affected by extracellular matrix (2014) (0)
Idiotipy of monoclonal antibodies to HLA-DR antigens as a means for further definition of HLA-DR antibodies (1982) (0)
A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer (2017) (0)
VP30.01: Cell‐free DNA screening for 22q11.2DS by targeted method based on microarray quantitation in the average risk population: results from a single European laboratory (2020) (0)
Variable Cell Line Pharmacokinetics Contribute to Non-Linear Treatment Response in Heterogeneous Cell Populations (2018) (0)
The involvement of laminin_5 in podosome formation (2006) (0)
Abstract P1-08-20: In silico analysis of a novel mathematical model integrating in vitro and in vivo imaging data reveals driving mechanisms of breast cancer response to NAT for personalized tumor forecasting (2022) (0)
Abstract A22: A window into 3D culture: A multi-modal imaging compatible bioreactor for developing tumor growth models (2017) (0)
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data (2019) (0)
Unified Tumor Growth Mechanisms from Multimodel Inference and Dataset Integration (2023) (0)
Ion channel dysregulation and ferroptosis susceptibility in a heterogeneous DTP state (2022) (0)
Biological Scales (2007) (0)
Abstract A43: BRAF-mutated melanomas exhibit distinct metabolic programs that may determine therapeutic response (2016) (0)
The role of MT4_MMP in renal development (2006) (0)
Determining the mechanism of integrin-laminin binding (2006) (0)
Keystone symposia on molecular & cellular biology announces (1992) (0)
Extracellular Matrix in Breast Cancer Invasion (2000) (0)
DDDR-28. EGFR AND SRC-MEDIATED ACTIVATION OF STAT3 DRIVES RESISTANCE TO MITOTIC INHIBITORS IN GLIOBLASTOMA, AND CAN BE REVERSED WITH FDA-APPROVED DRUGS (2022) (0)
Abstract 776: Multiscale treatment response model for triple-negative breast cancer linking drug pharmacokinetics to tumor cell population dynamics (2016) (0)
PD01-08: Heterogeneity of Lapatinib Responses in HCC1954 HER2−Overexpressing Breast Cancer Cells Revealed by Single-Cell Automated Microscopy. (2011) (0)
The role of MT1_MMP in renal development (2006) (0)
Quantifying Multi‐dimensional Drug Synergy along Axes of Potency and Efficacy in Anti‐Cancer Combinations (2018) (0)
Role of Integrin-Related Tyrosine Kinases in Growth Control of Normal and Tumorigenic Human Mammary Epithelium. (1995) (0)
Involvement of Epithelial–Mesenchymal Transition Genes in Small Cell Lung Cancer Phenotypic Plasticity (2022) (0)
Cells Surface markers of human pancreatic cancer cells (1988) (0)
Abstract PS13-44: Identifying relevant parameters that characterize the early response to NAT in breast cancer patients using a novel personalized mechanistic model integratingin vitroandin vivoimaging data (2021) (0)
Abstract 3747: Identification of NSCLC biomarkers underlying quantifiable drug-induced clonal fitness (2015) (0)

This paper list is powered by the following services:

Other Resources About Vito Quaranta

quarantalab.com

What Schools Are Affiliated With Vito Quaranta?

Vito Quaranta is affiliated with the following schools:

Vito Quaranta's Academic­Influence.com Rankings